Pharmaceuticals | India
Cadila Healthcare Ltd has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.
The financials pass all the three standards we check against.
Total Analysts: 30
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
|Dividends per Share||0.05|
Cadila Healthcare Limited is an India-based pharmaceutical company. The Company operates through two segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Company’s product portfolio includes the active pharmaceutical ingredients (API), human formulations, and animal health and veterinary. The Consumer Products segment represents the business of development, production, marketing and distribution of differentiated health and wellness products. The Company has a global presence and sells its products in the United States, India, Europe and other markets, including countries in Latin America, Asia Pacific region and Africa.
|✔ FTSE||✔ AAOIFI||✔ DJIM|
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.